Andreas Persidis, CEO Everybody agrees that the success of a drug increasingly depends on the total value it delivers. The commercial performance to date of Lundbeck’s antidepressant Brintellix is a case in point. Having demonstrated statistically significant efficacy over placebo in study results reported in 2012, Brintellix was approved by the FDA in 2013. Brintellix’s … Read More
CHARLOTTESVILLE, Virginia, June 23, 2015 /PRNewswire/ — French version German version Biovista Inc. today announced the publication of data from research it carried out in collaboration with the FDA and Israeli HMO Clalit, focusing on the prediction of risk factors related to targeted diseases. The research, published in the American Diabetes Association journal Diabetes … Read More
Apple’s strategy for its Apple Music service may offer an apt analogy to help us reframe the therapy research and development enterprise.
Drug combinations make sense both from the science and from the business perspective.